Latest / Diabetes Connections | Type 1 Diabetes
Why this endo is pushing for a diabetes drug you've probably never heard of (and the FDA has rejected).
We've got an important update on a diabetes drug you may have never heard about. Sotagliflozin is known to have big benefits for people with type 2 but getting it approved for type 1 has been frustrating to say the least.
The FDA has twice declined to approve it for people with T1D, but experts – including my guest – are pushing and hoping that will soon change. I'm talking to Dr. Steve Edleman, an endocrinologist who lives with type 1 and heads up the group Take Control of Your Diabetes – TCOYD.
We'll talk about the risks that come with sotogliflozin, how continuous ketone monitoring could…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.